"Marky's [KLEMPNER] Biowarfare Lab Under Fire Again"

[Mort Zuckerman]

To: Stanle...@fiu.edu, emcsw...@niaid.nih.gov,
afa...@niaid.nih.gov, Spin...@yahoogroups.com, kshe...@calea.org,
fit...@gmail.com, patrick.f...@usdoj.gov,
model...@sbcglobal.net, jdr...@nejm.org, let...@courant.com,
Jgerb...@cdc.gov, michae...@po.state.ct.us,
con...@po.state.ct.us, executiv...@nytimes.com, managing-
edi...@nytimes.com, news...@nytimes.com, the-...@nytimes.com,
biz...@nytimes.com, for...@nytimes.com, nati...@nytimes.com,
dv...@cdc.gov, brigidc...@optonline.net, tr...@hotmail.com,
illino...@aol.com, jle...@courant.com, tinaj...@yahoo.com,
jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, brans...@comcast.net,
vts...@comcast.net, o...@po.state.ct.us, freet...@charter.net,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov,
Robert....@yale.edu, edi...@greenwich-post.com,
harol...@yale.edu
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, afa...@niaid.nih.gov,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, richar...@yale.edu,
harol...@yale.edu, james.p...@yale.edu, inq...@aldf.com,
ly...@idsociety.org

Subject: "Marky's [KLEMPNER] Biowarfare Lab Under Fire Again"

Date: May 2, 2009 3:29 AM

The guy is a liar and a nutcase and the
CDC disowned his work, as shown by the Volkman
Rebuttal (seen on my homepage).

Now check out the audiotape of Marky talking
about how he found a nearly 8 times association
to a Multiple Sclerosis Haplotype, when discussing
his 4.7 million dollar "study" of "We-Don't-Know-
What-Dearborn-Means" (Phil Molloy of Imugen, Norwood,
Massachusetts):
http://www.actionlyme.org/YOUTUBEVIDEOS.htm
(DQB1-0602)
but how he and Gary Wormser, 6 YEARS LATER, report
that there is no such association:
http://www.actionlyme.org/MKLEMPNER.htm

Why'd we have to wait 12 years for Mark Klempner's
NO DATA, only to have the CDC disown it all?

And this guy should run a Level IV biolab?

He's a *mass-murderer,* here and in Europe.

Mark Klempner, himself, is a bioweapon.

A weapon, CLEARLY, of mass destruction.


Here he is talking about how ceftriaxone
failed in 1992:
http://www.actionlyme.org/MarkKlempner_Fibroblasts.htm

Now he says such a disease does not exist.

KMDickson
http://www.actionlyme.org
==============================
From: Mi
To: Spin...@yahoogroups.com

Subject: [SpinLyme] Marky's Biowarfare Lab Under Fire Again
Date: May 1, 2009 11:58 PM

At least we now know he isn't researching Lyme disease...

"The mission is to find ways to treat and prevent naturally occurring
infectious diseases," Klempner said.

Marky and his playpal Wormser already know a single dose of doxy cures
Lyme disease.

http://www.dailyfreepress.com/biolab-continues-to-face-setbacks-1.1718337

The Daily Free Press

Biolab continues to face setbacks
Megan Griffith

Published: Thursday, April 16, 2009

Updated: Thursday, April 16, 2009

Boston University's completed Biosafety Level-4 lab will not be able
to open and begin research until it settles two challenges mounted by
opponents of the facility that would house the world's deadliest
germs.

City Councilor Chuck Turner (Roxbury) called for the city to uphold a
1994 ban on rDNA, a hybrid genetic material often used in
sophisticated biomedical research, at a hearing Wednesday night.
Maintaining the ban is one way in which community opponents of the lab
hope to prevent its opening.

Also Wednesday, the National Institutes of Health announced it would
require at least a year more to ensure the lab is prepared for the
high-level research proposed for it, according to a Boston Globe
report. The NIH was ordered to perform a thorough safety review for
the lab, after an earlier one was deemed insufficient in federal
court.

The lab, located on BU's Medical Campus, was originally slated to open
for operation in 2007, though the arguments of residents and
scientists who say the lab does not belong in a densely populated,
urban area have so far prevented it.

Began in 2003, the project has cost $192 million. Scientists would
research Ebola, anthrax and other level-4 pathogens, some of the most
lethal and infectious diseases in the world, in the lab. Level-2 and 3
pathogens would also be researched in the same building.

Turner sponsored the hearing of the City Council's Environment and
Health Committee to address the extant city ordinance barring
recombinant DNA research.

"The Boston Public Health Commission regulation of 1994 states, 'rDNA
use requiring containment defined by the guidelines as Biosafety-Level
4 shall not be permitted in the City of Boston,'" Turner said to about
30 people at the meeting.

Harvard Medical School researcher John Goodenough said the biolab
would most likely use rDNA in research. It is a "standard tool in any
microbiology lab, especially one studying dangerous diseases," he
said.

"Vaccines for level-4 diseases such as Ebola are made with and contain
rDNA," Goodenough said.

However, Mark Klempner, the lab's director and BUMC associate provost
for research, said every research process would request and obtain
approval from the BPHC "at the concept stage."

"The mission is to find ways to treat and prevent naturally occurring
infectious diseases," Klempner said.

Goodenough said university research laboratories usually "make real
advances by dabbling" beyond the reach of their initially proposed
project - an "exciting, but potentially dangerous" prospect.

Turner asked Klempner to guarantee that the laboratory would not apply
for any projects involving rDNA, given the city regulations against
its use.

"There is no way to determine whether or not the BPHC will approve a
project," Klempner said.

Alternatives for Community and Environment member Eugene Benson said
BU officials failed to tell the NIH of the rDNA regulations in Boston
when the school was bidding for lab backing.

Benson read aloud a letter from August 2003 from the NIH to BU asking
how National Emerging Infectious Diseases Laboratories' proposed
level-4 lab could be built considering the BPHC's regulations, as well
as BU's response.

"Dr. Klempner's letter states that the regulations were 'not intended
in spirit or letter' to prohibit such research," Benson said.
"However, he is wrong on nearly seven out of 11 points in this
letter."

Klempner and other BU officials said their lack of clarity is because
the BPHC regulations on rDNA are vague as well, but Turner said the
NIH's new delays show the biolab proponents' arguments are weak.

"The researchers at NIH haven't been able to find a way to counter the
scientific argument that Boston is not an appropriate place for this,"
Turner said.

Turner said he hopes he can gather the support of at least seven city
councilors for an ordinance prohibiting the biolab's opening.

"Even if we only convince seven councilors to file an ordinance
against the BU laboratory and it is vetoed [by the mayor], we can send
a strong message that this is not a step that should be taken," he
said.


[Non-text portions of this message have been removed]